期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

卵巢癌预后因素的研究进展 被引量：1

Progress of prognostic factor of ovarian carcinoma
下载PDF
导出
摘要 卵巢癌是妇科恶性肿瘤中致死率最高的肿瘤,目前通常用于判断卵巢癌预后的指标有FIGO分期、肿瘤分级、肿瘤组织学类型等。近年来众多研究发现了许多具有判断卵巢癌预后潜力的标志物,现将近年来的研究进展综述如下。 Ovarian carcinoma is the most lethal gynecologic malignancy. Nowadays, conventional prognostic markers in ovarian cancer have included FIGO stage, tumor grade, histology et al. Recently many studies found out a lot of potential prognostic markers of ovarian carcinoma. We reviewed recent research progress.
作者 袁光文 吴令英
机构地区 中国医学科学院中国协和医科大学肿瘤医院妇瘤科
出处 《癌症进展》 2006年第1期57-60,81,共5页 Oncology Progress
关键词 卵巢癌 预后因素 ovarian carcinoma prognostic factor
分类号 R737.31 [医药卫生—肿瘤]
  • 相关文献

参考文献29

  • 1[1]Scorilas A,Borgono CA,Harbeck N,et al.Human kallikrein 13 protein in ovarian cancer cytosols:A new favorable prognostic marker.J Clin Oncol,2004,22 (4):678
  • 2[2]Munstedt K,Kovacic M,Zygmunt M,et al.Impact of hemoglobin levels before and during chemotherapy on survival of patients with ovarian cancer.Int J Oncol 2003,23 (3):837
  • 3[3]Li AJ,Madden AC,Cass I,et al.The prognostic significance of thrombocytosis in epithelial ovarian carcinoma.Gynecol Oncol,2004,92 (1):211
  • 4[4]Raspollini MR,Amunni G,Villanucci A,et al.Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma.Int J Gynecol Cancer,2004,14 (5):815
  • 5[5]Secord AA,Sayer R,Snyder SA,et al.The relationship between serum vascular endothelial growth factor,persistent disease,and survival at second-look laparotomy in ovarian cancer.Gynecol Oncol,2004,94 (1):74
  • 6[6]Yokoyama Y,Charnock-Jones DS,Licence D,et al.Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma.Br J Cancer,2003,88 (2):237
  • 7[7]Nishida N,Yano H,Komai K,et al.Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.Cancer,2004,101 (6):1364
  • 8[8]Estrid VS,Christensen L,Kjaer SK,et al.Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma:From the Danish MALOVA Ovarian Cancer,Study.Cancer 2003,98 (1):66
  • 9[9]Lassus H,Leminen A,Vayrynen A,et al.ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma.Gynecol Oncol,2004,92(1):31
  • 10[10]Reiner EK,Arnold N,Kommoss F,et al.The prognostic and predictive value of immunohistochemically detected HER-2/neu overexpression in 361 patients with ovarian cancer:A multicenter study.Gynecol Oncol,2004,95 (1):89

同被引文献4

引证文献1

二级引证文献1

癌症进展
2006年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部